UniProtKB - O14733 (MP2K7_HUMAN)
(max 400 entries)x
Your basket is currently empty.
Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)
Protein
Dual specificity mitogen-activated protein kinase kinase 7
Gene
MAP2K7
Organism
Homo sapiens (Human)
Status
Functioni
Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by proinflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis.4 Publications
Catalytic activityi
ATP + a protein = ADP + a phosphoprotein.
Cofactori
Enzyme regulationi
Activated by phosphorylation by specific MAP kinase kinase kinases such as MAP3K1/MEKK1, MAP3K3/MEKK3, MAP3K11/MLK3 and MAP3K12/DLK.2 Publications
Sites
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Binding sitei | 149 | ATPPROSITE-ProRule annotation | 1 | |
| Active sitei | 243 | Proton acceptorPROSITE-ProRule annotation | 1 |
Regions
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Nucleotide bindingi | 126 – 134 | ATPPROSITE-ProRule annotation | 9 |
GO - Molecular functioni
- ATP binding Source: UniProtKB-KW
- enzyme binding Source: BHF-UCL
- magnesium ion binding Source: UniProtKB
- MAP kinase kinase activity Source: UniProtKB
- protein kinase binding Source: UniProtKB
- protein phosphatase binding Source: BHF-UCL
- protein serine/threonine kinase activity Source: GO_Central
- protein tyrosine kinase activity Source: UniProtKB-KW
GO - Biological processi
- activation of JUN kinase activity Source: BHF-UCL
- apoptotic process Source: UniProtKB-KW
- Fc-epsilon receptor signaling pathway Source: Reactome
- JNK cascade Source: Reactome
- positive regulation of telomerase activity Source: BHF-UCL
- positive regulation of telomere capping Source: BHF-UCL
- positive regulation of telomere maintenance via telomerase Source: BHF-UCL
- proteolysis in other organism Source: Reactome
- regulation of apoptotic process Source: GO_Central
- regulation of mitotic cell cycle Source: GO_Central
- response to heat Source: UniProtKB
- response to osmotic stress Source: UniProtKB
- response to tumor necrosis factor Source: UniProtKB
- response to UV Source: UniProtKB
- signal transduction Source: ProtInc
- stress-activated MAPK cascade Source: UniProtKB
Keywordsi
| Molecular function | Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase |
| Biological process | Apoptosis, Stress response |
| Ligand | ATP-binding, Magnesium, Metal-binding, Nucleotide-binding |
Enzyme and pathway databases
| BRENDAi | 2.7.12.2. 2681. |
| Reactomei | R-HSA-2559580. Oxidative Stress Induced Senescence. R-HSA-2871796. FCERI mediated MAPK activation. R-HSA-450321. JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1. R-HSA-5210891. Uptake and function of anthrax toxins. |
| SignaLinki | O14733. |
| SIGNORi | O14733. |
Names & Taxonomyi
| Protein namesi | Recommended name: Dual specificity mitogen-activated protein kinase kinase 7 (EC:2.7.12.2)Short name: MAP kinase kinase 7 Short name: MAPKK 7 Alternative name(s): JNK-activating kinase 2 MAPK/ERK kinase 7 Short name: MEK 7 Stress-activated protein kinase kinase 4 Short name: SAPK kinase 4 Short name: SAPKK-4 Short name: SAPKK4 c-Jun N-terminal kinase kinase 2 Short name: JNK kinase 2 Short name: JNKK 2 |
| Gene namesi | Name:MAP2K7 Synonyms:JNKK2, MEK7, MKK7, PRKMK7, SKK4 |
| Organismi | Homo sapiens (Human) |
| Taxonomic identifieri | 9606 [NCBI] |
| Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
| Proteomesi |
|
Organism-specific databases
| HGNCi | HGNC:6847. MAP2K7. |
Pathology & Biotechi
Organism-specific databases
| DisGeNETi | 5609. |
| OpenTargetsi | ENSG00000076984. |
| PharmGKBi | PA284. |
Chemistry databases
| ChEMBLi | CHEMBL3530. |
| GuidetoPHARMACOLOGYi | 2068. |
Polymorphism and mutation databases
| BioMutai | MAP2K7. |
PTM / Processingi
Molecule processing
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Initiator methioninei | RemovedCombined sources | |||
| ChainiPRO_0000086388 | 2 – 419 | Dual specificity mitogen-activated protein kinase kinase 7Add BLAST | 418 |
Amino acid modifications
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Modified residuei | 2 | N-acetylalanineCombined sources | 1 | |
| Modified residuei | 271 | Phosphoserine; by MAP3KBy similarity | 1 | |
| Modified residuei | 275 | Phosphothreonine; by MAP3KBy similarity | 1 | |
| Modified residuei | 411 | PhosphoserineCombined sources | 1 |
Post-translational modificationi
Activated by phosphorylation on Ser-271 and Thr-275 by MAP kinase kinase kinases (MAP3Ks).By similarity
Sites
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Sitei | 44 – 45 | Cleavage; by anthrax lethal factor | 2 | |
| Sitei | 76 – 77 | Cleavage; by anthrax lethal factor | 2 |
Keywords - PTMi
Acetylation, PhosphoproteinProteomic databases
| EPDi | O14733. |
| MaxQBi | O14733. |
| PaxDbi | O14733. |
| PeptideAtlasi | O14733. |
| PRIDEi | O14733. |
PTM databases
| iPTMneti | O14733. |
| PhosphoSitePlusi | O14733. |
Miscellaneous databases
| PMAP-CutDBi | O14733. |
Expressioni
Tissue specificityi
Ubiquitous; with highest level of expression in skeletal muscle. Isoform 3 is found at low levels in placenta, fetal liver, and skeletal muscle.3 Publications
Gene expression databases
| Bgeei | ENSG00000076984. |
| CleanExi | HS_MAP2K7. |
| Genevisiblei | O14733. HS. |
Organism-specific databases
| HPAi | CAB004262. HPA001633. HPA064711. |
Interactioni
Subunit structurei
Interacts with isoform 1 of VRK2. Interacts (via its D domain) with its substrates MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3 (By similarity). Interacts (via its DVD domain) with MAP3Ks activators like MAP3K5/ASK1 and MAP3K1/MEKK1 (By similarity). Interacts with MAPK8IP1/JIP1, MAPK8IP2/JIP2 and MAPK8IP3/JIP3 scaffold proteins. Interacts with RASSF7, the interaction promotes phosphorylation.By similarity4 Publications
Binary interactionsi
GO - Molecular functioni
- enzyme binding Source: BHF-UCL
- protein kinase binding Source: UniProtKB
- protein phosphatase binding Source: BHF-UCL
Protein-protein interaction databases
| BioGridi | 111595. 57 interactors. |
| IntActi | O14733. 25 interactors. |
| MINTi | MINT-1378223. |
| STRINGi | 9606.ENSP00000381066. |
Chemistry databases
| BindingDBi | O14733. |
Structurei
Secondary structure
Legend: HelixTurnBeta strandPDB Structure known for this area
Show more details| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Beta strandi | 105 – 108 | Combined sources | 4 | |
| Beta strandi | 111 – 114 | Combined sources | 4 | |
| Helixi | 117 – 119 | Combined sources | 3 | |
| Beta strandi | 120 – 127 | Combined sources | 8 | |
| Beta strandi | 129 – 131 | Combined sources | 3 | |
| Beta strandi | 134 – 139 | Combined sources | 6 | |
| Turni | 140 – 142 | Combined sources | 3 | |
| Beta strandi | 145 – 152 | Combined sources | 8 | |
| Helixi | 157 – 172 | Combined sources | 16 | |
| Turni | 173 – 175 | Combined sources | 3 | |
| Beta strandi | 182 – 187 | Combined sources | 6 | |
| Beta strandi | 189 – 196 | Combined sources | 8 | |
| Beta strandi | 200 – 202 | Combined sources | 3 | |
| Helixi | 203 – 210 | Combined sources | 8 | |
| Helixi | 216 – 237 | Combined sources | 22 | |
| Helixi | 246 – 248 | Combined sources | 3 | |
| Beta strandi | 249 – 251 | Combined sources | 3 | |
| Beta strandi | 257 – 259 | Combined sources | 3 | |
| Turni | 262 – 265 | Combined sources | 4 | |
| Helixi | 281 – 283 | Combined sources | 3 | |
| Helixi | 286 – 289 | Combined sources | 4 | |
| Beta strandi | 292 – 297 | Combined sources | 6 | |
| Helixi | 302 – 317 | Combined sources | 16 | |
| Turni | 321 – 324 | Combined sources | 4 | |
| Helixi | 328 – 337 | Combined sources | 10 | |
| Beta strandi | 345 – 347 | Combined sources | 3 | |
| Helixi | 351 – 360 | Combined sources | 10 | |
| Helixi | 365 – 367 | Combined sources | 3 | |
| Helixi | 371 – 374 | Combined sources | 4 | |
| Helixi | 378 – 385 | Combined sources | 8 | |
| Helixi | 390 – 400 | Combined sources | 11 |
3D structure databases
| Select the link destinations: PDBei RCSB PDBi PDBji Links Updated | PDB entry | Method | Resolution (Å) | Chain | Positions | PDBsum |
| 2DYL | X-ray | 2.45 | A | 101-405 | [»] | |
| 3WZU | X-ray | 3.01 | A | 103-419 | [»] | |
| 4UX9 | X-ray | 2.34 | F/G/H/I | 37-48 | [»] | |
| 5B2K | X-ray | 2.75 | A | 103-419 | [»] | |
| 5B2L | X-ray | 2.10 | A | 103-419 | [»] | |
| 5B2M | X-ray | 3.06 | A | 103-419 | [»] | |
| DisProti | DP00841. | |||||
| ProteinModelPortali | O14733. | |||||
| SMRi | O14733. | |||||
| ModBasei | Search... | |||||
| MobiDBi | Search... | |||||
Miscellaneous databases
| EvolutionaryTracei | O14733. |
Family & Domainsi
Domains and Repeats
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Domaini | 120 – 380 | Protein kinasePROSITE-ProRule annotationAdd BLAST | 261 |
Region
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Regioni | 37 – 57 | D domainBy similarityAdd BLAST | 21 | |
| Regioni | 377 – 400 | DVD domainAdd BLAST | 24 |
Coiled coil
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Coiled coili | 2 – 30 | Sequence analysisAdd BLAST | 29 |
Domaini
The DVD domain (residues 377-400) contains a conserved docking site and is found in the mammalian MAP kinase kinases (MAP2Ks). The DVD sites bind to their specific upstream MAP kinase kinase kinases (MAP3Ks) and are essential for activation.1 Publication
The D domain (residues 37-57) contains a conserved docking site and is required for the binding to MAPK substrates.1 Publication
Sequence similaritiesi
Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase subfamily.Curated
Keywords - Domaini
Coiled coilPhylogenomic databases
| eggNOGi | KOG0983. Eukaryota. ENOG410XTNQ. LUCA. |
| GeneTreei | ENSGT00760000119199. |
| HOVERGENi | HBG108518. |
| InParanoidi | O14733. |
| KOi | K04431. |
| OMAi | HPVIVIT. |
| OrthoDBi | EOG091G0A9H. |
| PhylomeDBi | O14733. |
| TreeFami | TF350701. |
Family and domain databases
| InterProi | View protein in InterPro IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_dom. IPR008271. Ser/Thr_kinase_AS. |
| Pfami | View protein in Pfam PF00069. Pkinase. 1 hit. |
| SMARTi | View protein in SMART SM00220. S_TKc. 1 hit. |
| SUPFAMi | SSF56112. SSF56112. 1 hit. |
| PROSITEi | View protein in PROSITE PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. |
Sequences (4)i
Sequence statusi: Complete.
Sequence processingi: The displayed sequence is further processed into a mature form.
This entry describes 4 isoformsi produced by alternative splicing. AlignAdd to basket
Isoform 1 (identifier: O14733-1) [UniParc]FASTAAdd to basket
Also known as: A
This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
10 20 30 40 50
MAASSLEQKL SRLEAKLKQE NREARRRIDL NLDISPQRPR PTLQLPLAND
60 70 80 90 100
GGSRSPSSES SPQHPTPPAR PRHMLGLPST LFTPRSMESI EIDQKLQEIM
110 120 130 140 150
KQTGYLTIGG QRYQAEINDL ENLGEMGSGT CGQVWKMRFR KTGHVIAVKQ
160 170 180 190 200
MRRSGNKEEN KRILMDLDVV LKSHDCPYIV QCFGTFITNT DVFIAMELMG
210 220 230 240 250
TCAEKLKKRM QGPIPERILG KMTVAIVKAL YYLKEKHGVI HRDVKPSNIL
260 270 280 290 300
LDERGQIKLC DFGISGRLVD SKAKTRSAGC AAYMAPERID PPDPTKPDYD
310 320 330 340 350
IRADVWSLGI SLVELATGQF PYKNCKTDFE VLTKVLQEEP PLLPGHMGFS
360 370 380 390 400
GDFQSFVKDC LTKDHRKRPK YNKLLEHSFI KRYETLEVDV ASWFKDVMAK
410
TESPRTSGVL SQPHLPFFR
Sequence cautioni
The sequence AAB97813 differs from that shown. Reason: Erroneous termination at position 420. Translated as stop.Curated
Experimental Info
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Sequence conflicti | 94 | Q → H in AAB97813 (PubMed:9312068).Curated | 1 | |
| Sequence conflicti | 106 | L → P in ABE03013 (PubMed:16442502).Curated | 1 | |
| Sequence conflicti | 133 | Q → P in AAB97813 (PubMed:9312068).Curated | 1 | |
| Sequence conflicti | 142 | T → N in AAB88048 (PubMed:9372971).Curated | 1 | |
| Sequence conflicti | 407 | S → N in AAB97813 (PubMed:9312068).Curated | 1 | |
| Sequence conflicti | 415 | L → LG in AAB97813 (PubMed:9312068).Curated | 1 |
Natural variant
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_040825 | 118 | N → S1 PublicationCorresponds to variant dbSNP:rs56316660Ensembl. | 1 | |
| Natural variantiVAR_040826 | 138 | R → C1 PublicationCorresponds to variant dbSNP:rs56106612Ensembl. | 1 | |
| Natural variantiVAR_040827 | 162 | R → C in a colorectal adenocarcinoma sample; somatic mutation. 1 Publication | 1 | |
| Natural variantiVAR_040828 | 162 | R → H in a colorectal adenocarcinoma sample; somatic mutation. 1 Publication | 1 | |
| Natural variantiVAR_040829 | 195 | A → T1 PublicationCorresponds to variant dbSNP:rs55800262Ensembl. | 1 | |
| Natural variantiVAR_029890 | 259 | L → F1 PublicationCorresponds to variant dbSNP:rs1053566Ensembl. | 1 |
Alternative sequence
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Alternative sequenceiVSP_022309 | 42 | T → IIVITLSPAPAPSQRAA in isoform 3. 1 Publication | 1 | |
| Alternative sequenceiVSP_004883 | 111 | Q → QVPPSLWRGEGGGPARLDPS WERQWGAGGGGRAPGTLQPS LSSQ in isoform 2. 1 Publication | 1 | |
| Alternative sequenceiVSP_022310 | 312 | L → LPCPSPSQ in isoform 4. 1 Publication | 1 |
Sequence databases
| Select the link destinations: EMBLi GenBanki DDBJi Links Updated | AF014401 mRNA. Translation: AAB88048.1. AF006689 mRNA. Translation: AAB97813.1. Sequence problems. AF013588 mRNA. Translation: AAC16272.1. AF013589 mRNA. Translation: AAC16273.1. DQ445915 mRNA. Translation: ABE03013.1. AF022805 mRNA. Translation: AAC26142.1. AK313899 mRNA. Translation: BAG36622.1. CH471139 Genomic DNA. Translation: EAW68964.1. CH471139 Genomic DNA. Translation: EAW68968.1. BC038295 mRNA. Translation: AAH38295.1. AF003199 mRNA. Translation: AAB63374.1. |
| CCDSi | CCDS42491.1. [O14733-1] CCDS74277.1. [O14733-3] CCDS74278.1. [O14733-4] |
| RefSeqi | NP_001284484.1. NM_001297555.1. [O14733-3] NP_001284485.1. NM_001297556.1. [O14733-4] NP_660186.1. NM_145185.3. [O14733-1] |
| UniGenei | Hs.531754. |
Genome annotation databases
| Ensembli | ENST00000397979; ENSP00000381066; ENSG00000076984. [O14733-1] ENST00000397981; ENSP00000381068; ENSG00000076984. [O14733-4] ENST00000397983; ENSP00000381070; ENSG00000076984. [O14733-3] |
| GeneIDi | 5609. |
| KEGGi | hsa:5609. |
| UCSCi | uc002mit.4. human. [O14733-1] |
Keywords - Coding sequence diversityi
Alternative splicing, PolymorphismSimilar proteinsi
Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:| 100% | UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into one UniRef entry. |
| 90% | UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence). |
| 50% | UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster. |
Entry informationi
| Entry namei | MP2K7_HUMAN | |
| Accessioni | O14733Primary (citable) accession number: O14733 Secondary accession number(s): B2R9S5 Q8IY10 | |
| Entry historyi | Integrated into UniProtKB/Swiss-Prot: | May 30, 2000 |
| Last sequence update: | May 30, 2000 | |
| Last modified: | July 5, 2017 | |
| This is version 172 of the entry and version 2 of the sequence. See complete history. | ||
| Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
| Annotation program | Chordata Protein Annotation Program | |
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | |
Miscellaneousi
Keywords - Technical termi
3D-structure, Complete proteome, Reference proteomeDocuments
- Human chromosome 19
Human chromosome 19: entries, gene names and cross-references to MIM - Human entries with polymorphisms or disease mutations
List of human entries with polymorphisms or disease mutations - Human polymorphisms and disease mutations
Index of human polymorphisms and disease mutations - MIM cross-references
Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot - PDB cross-references
Index of Protein Data Bank (PDB) cross-references - Human and mouse protein kinases
Human and mouse protein kinases: classification and index - SIMILARITY comments
Index of protein domains and families
